NCT04913402

Brief Summary

The new competence of paramedics to administer opioid analgesics in acute trauma patients without presence or phone-call consult with an emergency medical doctor will be assessed in this study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
158

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 14, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 23, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2021

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

May 17, 2021

Completed
18 days until next milestone

First Posted

Study publicly available on registry

June 4, 2021

Completed
Last Updated

June 4, 2021

Status Verified

May 1, 2021

Enrollment Period

6 months

First QC Date

May 17, 2021

Last Update Submit

May 31, 2021

Conditions

Keywords

SufentanilParamedicAcute trauma injuryPrehospital emergency care

Outcome Measures

Primary Outcomes (6)

  • The safety of pain treatment by the paramedics with competence to sufentanil - administration in acute trauma - incidence of apnea

    Measurement of incidence of adverse effects of sufentanil administration in both study groups - apnea - during the period from sufentanil administration (baseline) up to handover of the patient to the hospital (percentage).

    After sufentanil administration up to the handover of the patient to the hospital, up to 60 minutes.

  • The safety of pain treatment by the paramedics with competence to sufentanil - administration in acute trauma - incidence of bradypnoea

    Measurement of incidence of adverse effects of sufentanil administration in both study groups - bradypnoea - is measured during the period from sufentanil administration (baseline) up to handover of the patient to the hospital (percentage).

    After sufentanil administration up to the handover of the patient to the hospital, up to 60 minutes.

  • The safety of pain treatment by the paramedics with competence to sufentanil - administration in acute trauma - incidence of nausea.

    Measurement of incidence of adverse effects of sufentanil administration in both study groups - nausea - is measured during the period from sufentanil administration (baseline) up to handover of the patient to the hospital (percentage).

    After sufentanil administration up to the handover of the patient to the hospital, up to 60 minutes.

  • The safety of pain treatment by the paramedics with competence to sufentanil administration in acute trauma - incidence of bradypnoea.

    Measurement of incidence of adverse effects of sufentanil administration in both study groups - vomiting - is measured during the period from sufentanil administration (baseline) up to handover of the patient to the hospital (percentage).

    After sufentanil administration up to the handover of the patient to the hospital, up to 60 minutes.

  • The efficacy of pain treatment by the paramedics with competence to sufentanil - administration in acute trauma - visual analogue scale.

    The ten point Visual analogue scale is used to measure the efficacy of pain treatment. The difference of VAS before administration of sufentanil and at the handover at the emergency department is calculated and compared in both groups (in points).

    Before sufentanil administration and at the handover of the patient to the hospital, up to 60 minutes.

  • The efficacy of pain treatment by the paramedics with competence to sufentanil -administration in acute trauma - numeric rating scale.

    The ten point Numeric rating scale (NRS) is used to measure the efficacy of pain treatment. The difference of NRS before administration of sufentanil and at the handover at the emergency department is calculated and compared in both groups (in points).

    Before sufentanil administration and at the handover of the patient to the hospital, up to 60 minutes.

Secondary Outcomes (8)

  • Dose of administered sufentanil

    After sufentanil administration, up to 60 minutes.

  • Incidence of potentiation of analgesia by other analgesics

    After sufentanil administration, up to 60 minutes.

  • Types of drugs used for potentiation of analgesia by sufentanil

    After sufentanil administration, up to 60 minutes.

  • The influence on haemodynamic parameters - non invasive blood pressure (BP) -systolic blood pressure

    Before sufentanil administration and at the time of the handover in hospital, up to 60 minutes.

  • The influence on haemodynamic parameters - non invasive blood pressure (BP) - diastolic blood pressure

    Before sufentanil administration and at the time of the handover in hospital, up to 60 minutes.

  • +3 more secondary outcomes

Study Arms (2)

Consultation

Patient who were administered sufentanil in acute trauma by paramedics after phone call consultation with medical doctor.

Other: Sufentanil administered by paramedics after the phone call consultation of medical doctor.

Competency

Patient who were administered sufentanil in acute trauma by paramedics with competence to administer sufentanil without any consultation with medical doctor.

Other: Sufentanil administered by paramedics based on their competency, without consultation of medical doctor.

Interventions

Administration of sufentanil to patients with acute injury by paramedics only after phone-call consultation of medical doctor.

Consultation

Administration of sufentanil to patients with acute injury by paramedics with competency to administer sufentanil without medical doctor consultation.

Competency

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults patient in prehospital emergency care, who suffered acute trauma with severe pain.

You may qualify if:

  • acute trauma with severe pain (VAS/NRS \> 4)
  • age \> 18 years
  • conscious patient (GCS = 15; alert in AVPU)
  • haemodynamically stable patient (\> 100mmHg of systolic blood pressure, \> 60/min of heart rate)

You may not qualify if:

  • doctor on site
  • paediatric patient
  • predominantly chronic but not acute pain
  • incomplete documentation
  • other than traumatic reasons for opioid administration (eg. acute coronary syndrome)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zdravotnická záchranná služba Karlovarského kraje, p.o.

Karlovy Vary, Karlovarský kraj, 360 06, Czechia

Location

Related Publications (2)

  • Gnirke A, Beckers SK, Gort S, Sommer A, Schroder H, Rossaint R, Felzen M. [Analgesia in the emergency medical service: comparison between tele-emergency physician and call back procedure with respect to application safety, effectiveness and tolerance]. Anaesthesist. 2019 Oct;68(10):665-675. doi: 10.1007/s00101-019-00661-0. Epub 2019 Sep 5. German.

    PMID: 31489458BACKGROUND
  • Scharonow M, Alberding T, Oltmanns W, Weilbach C. Project for the introduction of prehospital analgesia with fentanyl and morphine administered by specially trained paramedics in a rural service area in Germany. J Pain Res. 2017 Nov 6;10:2595-2599. doi: 10.2147/JPR.S151077. eCollection 2017.

Related Links

MeSH Terms

Conditions

Accidental InjuriesPain

Condition Hierarchy (Ancestors)

Wounds and InjuriesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Roman SYKORA, PhD

    Emergency Medical Service of Karlovy Vary Region, Czech Republic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research coordinator

Study Record Dates

First Submitted

May 17, 2021

First Posted

June 4, 2021

Study Start

September 14, 2020

Primary Completion

March 23, 2021

Study Completion

May 15, 2021

Last Updated

June 4, 2021

Record last verified: 2021-05

Locations